This morning the Enzolytics Inc (OTCMKTS:ENZC) stock has made a strong move and rallied by 10% after the company announced definite plans to advance its anti-HIV and ITV-1 therapeutic products.
The company announced that it is going to take those two products through clinical trials and then distribute them all across Europe. Once these steps are completed, it will help in establishing its anti-HIV therapy as one of the important generators of revenue for Enzolytics. That will be an important outcome not only for HIV treatment but also for the company’s financial health.
On the other hand, the ITV-1 anti-HIV therapeutics product had made considerable progress in the past and had been on the verge of getting certified by the Bulgarian Drug Agency. Hence, today’s appointment gives a much clearer indication of the company’s immediate goals. It will be a good move for investors to keep an eye on the announcement being made by the company over the coming days.